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Abstract Introduction: Little is known about the com-
pleteness and timely administration of recommended
standard immunizations in Germany. The goal of this
study was to determine compliance with official standard
immunization recommendations in adolescents attending
secondary schools in the city of Erlangen, Germany.
Methods: Adolescents who were attending 5th grade (at
approximately 11 years of age), 8th grade (14 years), or
10th and 11th grade (16–17 years) classes at any of the
13 of 14 schools that had agreed to participate were
eligible to be enrolled. Results: While coverage for the
primary series of diphtheria, tetanus and poliomyelitis
immunizations was satisfactory (98%), coverage for
measles-mumps-rubella immunizations (dose 1: 89–96%;
dose 2: 60–76%) and hepatitis B (doses 1–3: 61%) was
suboptimal. Of note, 39% of students had not received any
immunization against pertussis. Completion of immuniza-
tion series generally was significantly delayed. Fur-
thermore, rates for recommended booster doses in adoles-
cence were disappointingly low with 21% for tetanus
component vaccines and <10% for the fifth dose of
pertussis. Conclusions: Significant immunization gaps
for all recommended standard immunizations in adoles-
cents were detected. This puts individuals at risk for
serious vaccine-preventable diseases, contributes to sub-
optimal herd immunity in the population under study
leaving the potential for future epidemics, and impedes
national and international targets of disease reduction or
elimination.
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Abbreviations DTPa: Diphtheria, tetanus, acellular
pertussis component vaccine . IPV: Inactivated
poliomyelitis vaccine . OPV: Oral poliomyelitis vaccine .
Hib: Haemophilus influenzae type B vaccine . hep B:
Hepatitis B vaccine . MMR: Measles, mumps, rubella
vaccine . Td: Reduced diphtheria toxoid and tetanus toxoid
vaccine . Tdpa: Td, plus reduced antigen acellular pertussis
component vaccine
Introduction
Virtually all countries worldwide recommend specific
immunizations for the general population [22]. Some
countries regularly analyze compliance with recommended
immunizations, and this is usually based on immunization
coverage in young children [4, 8, 12–14, 16]. However,
little is known about compliance with recommended
standard or catch-up immunizations in adolescents, and
data are frequently limited to specific immunizations such
as those against hepatitis B [5, 7, 9]. Further, assessment of
timely immunization has not been reported in adolescents
so far.
Currently the recommendations for standard immuniza-
tions for children and adolescents in Germany comprise
vaccinations against 10 diseases: DTPa-IPV-hepB/Hib (at
2, 3, 4, and 11–14 months of age), MMR (11–14 and 15–
23 months), varicella (11 months of age onwards), Td (5–
6 years), and Tdpa-IPV (9–17 years) [17]. Over the last
15 years these recommendations, as issued by the German
national advisory board for immunizations, the Ständige
Impfkommission am Robert Koch-Institut (STIKO), have
undergone several modifications which can be summarized
as follows.
Immunization against Hib was introduced in spring of
1990. In 1991, a second dose of MMR was recommended
at 5–6 years of age (later modified to the second year of
life) and as a catch-up immunization for all older children
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and adolescents. Also in 1991, universal pertussis im-
munization was re-introduced after 25 years of cessation
(in former West Germany) with three doses in the first
year of life, a fourth dose in the second year of life, and
catch-up immunizations to be performed in all unvacci-
nated children (four doses) and adolescents (two instead of
four doses from 14 years of age onwards). Further, a fifth
dose of pertussis vaccine was introduced in July 2000 for
those 9–17 years of age. Universal immunization against
hepatitis B was introduced in children (2 months of age
onwards) and adolescents (9–17 years) in 1995. Finally,
varicella immunization has been recommended in infants
11 months of age and older (with catch-up immunization in
unvaccinated older children and adolescents without a
history of previous varicella) since July 2005.
The primary goal of this cross-sectional study was to
assess the compliance with a fifth dose of pertussis vaccine
in adolescents in Erlangen, Germany, more than 1 year
after its introduction in the national immunization sched-
ule. As secondary goals we were interested in immuniza-
tion coverage with other standard immunizations in
adolescents and how timely they were administered.
Methods
Study cohort and data collection
The study was planned in collaboration with the local
Public Health Service; and the heads of all 14 secondary
schools in Erlangen, Germany, were asked for their
agreement after the design of the study had been explained
in a letter in December 2001. All students attending 5th
grade (at approximately 11 years of age), 8th grade
(14 years), or 10th and 11th grade (16–17 years) classes at
any of the 13 schools that had agreed to participate were
eligible to be enrolled. The students and their parents were
informed by a letter about the purpose of the study in
January 2002, and the students were asked to bring their
immunization records to school on a pre-determined date
(between January and March 2002) for inspection by one
of us (KL) if they were willing to participate.
Definitions
In accordance with the German national immunization
recommendations, age-appropriate immunization in study
subjects was defined as follows:
– A primary series of three doses of DTP/DTPa
combination vaccine and a fourth dose at least 6 months
after the third dose (two plus one doses if DT only),
followed by further doses of Td at 5–6 years of age, a
Td combination vaccine from 9 years of age onwards,
and one further dose of pertussis vaccine (either in
combination with Td or as a monovalent vaccine) from
9 years of age onwards
– Four doses of OPV and/or IPV before the child’s
second birthday and a fifth dose from 9 years of age
onwards
– At least one dose of Hib vaccine after 12 months of age
in adolescents who were <5 years old (upper limit for
recommended immunization) in 1990 when this vac-
cine was introduced, i.e. 5th and 8th grade students
– Three doses of monovalent hepatitis B vaccine (0, 1,
6 month schedule)
– Two doses of MMR, at least 4 weeks apart
Reasons for Exclusion
Students eligible for participation:
n=3079
(100%)
Lack of immunization records: n=89  (2.9%)
Prolonged sick leave: n=21 (0.7%)
Included in final analysis: n=1672
(54.3%)
Refusal: n=851 (27.6 %)
No reply: n=446 (14.5 %)
Fig. 1 Study flow chart
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Statistical analysis
Statistical analyses were performed with SPSS version 11.0
(SPSS, Chicago, IL, United States).
Ethical approval
The study protocol was approved by the University of
Erlangen Medical Faculty Ethical Committee.
Results
Study participants
There were 1,672 adolescents who participated in this
study (Fig. 1), of whom 747 (44.7%), 646 (38.6%), and
279 (16.7%) were attending 5th grade, 8th grade, and
10th/11th grade classes, respectively. Participation rates
decreased with increasing grade from 64.6 to 53.3 and
39.2% (P<0.001). Further, overall participation rate was
higher in high schools (62.5%) compared to other second-
ary schools (45.1%; P<0.001).
Immunization coverage
The great majority of adolescents had a documented
primary series of immunizations against diphtheria [98.1%;
95% confidence interval (CI): 97.5–98.7], tetanus (98.5%;
95% CI: 97.9–99.1) and poliomyelitis (97.7%; 95%VB:
96.9–98.5). In contrast, only 650 (87.0%) of 747 5th grade
students and 316 (48.9%) of 646 8th grade students had
received age-appropriate numbers of Hib immunizations
before 5 years of age.
With regards to further booster immunizations with
tetanus component vaccines, 91.9% of students had
received the recommended pre-school dose (Table 1).
Administration of the adolescent booster, recommended
between 9 and 17 years of age, was less complete although
rates increased steadily from grade to grade. Similar
findings were obtained for diphtheria and poliomyelitis
immunizations (data not shown).
With regards to hepatitis B, only 1,014 (60.6%) of 1,672
students had been completely (≥three doses) immunized at
any age, and in a further 175 (10.5%) individuals, the series
had been initiated with one or two doses but had not yet
been completed.
As can be seen in Table 2, 95–96% of female and male
adolescents had received at least one dose of measles and
mumps vaccine and 75–78% had received at least two
doses. In contrast, rates for rubella immunization were
below 90% and approximately 60% for the first and second
doses, respectively, in both females and males. However,
coverage with one and two doses of rubella vaccine
increased from 82.8 and 43.7% in 10th and 11th grade
students to 91.8 and 65.5% in 5th grade students
(P<0.001), respectively.
Pertussis immunization coverage and age when the first
dose had been administered are presented in Table 3.
Although 60.7% of students had received at least one dose
(71.6% of 5th grade, 50.2% of 8th grade, and 56.7% of
10th/11th grade students), only a minority of students had
received an age-appropriate number of doses. Of those with
initiation of immunization before 1 year of age, only 123
(7.4%) had received the full series of five doses and,
interestingly, 50 of these 123 students had received their
fifth dose before 9 years of age, i.e. earlier than generally
recommended (Fig. 2). Further, 24 (1.5%) students had
received at least two doses (the recommended total number
when administered as a primary series between 14 and
18 years of age) of monovalent acellular pertussis vaccine
at 14 years of age or older. Still, overall less than 10% of
adolescents were up-to-date regarding pertussis immuniza-
tions, and the rate among the oldest students (10th and 11th
grade) did not exceed 10% either. Approximately 40% of
adolescents had never received any immunization against
pertussis with a disproportionately higher percentage
among 10th and 11th grade students compared to 5th
grade students (28.4% versus 47.9%; P<0.001).
Timely administration of immunizations
Immunizations where significantly delayed when com-
pared to officially recommended time points. By use of
data for tetanus immunizations as an indicator of com-
bination vaccines administered in the first year of life, only
60.3% of students had received a complete primary series
by 6 months of age and 84.2% had received a booster dose
in the second year of life. Further booster doses were
Table 1 Immunization coverage for tetanus pre-school and adolescent booster doses in 1,672 students
Study population Booster ≤6 years, n (%) 7–8 years, n (%) ≥9 years, n (%) Total, n (%)
Total (n=1,672) Pre-school booster 482 (28.8) 848 (50.7) 206 (12.3) 1,536 (91.9)
Adolescent booster 12 (0.7) 26 (1.6) 319 (19.1) 357 (21.4)
5th grade (n=747) Pre-school booster 242 (32.4) 356 (47.7) 66 (8.8) 664 (88.9)
Adolescent booster 7 (0.9) 11 (1.5) 26 (3.5) 44 (5.9)
8th grade (n=646) Pre-school booster 171 (26.5) 360 (55.7) 84 (13.0) 615 (95.2)
Adolescent booster 4 (0.6) 13 (2.0) 167 (25.9) 184 (28.5)
10th/11th grade (n=279) Pre-school booster 69 (24.7) 132 (47.3) 56 (20.1) 257 (92.1)
Adolescent booster 1 (0.4) 2 (0.7) 126 (45.2) 129 (46.2)
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substantially delayed in the great majority of students, with
less than a third having received the recommended pre-
school booster before school entry and merely a fifth
having received the adolescent age booster. Even in 10th or
11th grade students, 16–17 years of age and therefore at the
end of the recommended time window, less than 50% were
up-to-date with their tetanus (and diphtheria) immunization
schedule.
Since pertussis vaccinations in childhood are usually
administered as part of DTP/DTPa and Tdpa combination
vaccines, delay of immunization for doses one through
five followed the same pattern as described for tetanus
vaccinations. Furthermore, recommended pertussis mono-
valent catch-up immunizations in those students who had
received DT combination vaccines in childhood were
administered only in a small minority.
Administration of the second dose of MMR was
scattered throughout pre-school and school age as is
exemplified for measles vaccinations in 8th grade students
in Fig. 3. Two peaks of immunization around school entry
(6–7 years of age) and transition to secondary school (10–
11 years of age) can be recognized, which coincide with
scheduled “well-child visits” in private practices and public
health service visits to schools, respectively.
Disease surveillance
According to the Protection Against Infectious Disease
law (“Infektionsschutzgesetz”), introduced in Germany in
2001, reporting of several vaccine-preventable diseases is
mandatory. Unfortunately, pertussis is not.
With regards to hepatitis B, the yearly incidence (per
100,000 inhabitants) in the city of Erlangen decreased
from 1.9 in 2001 to 1.0 in 2005 and in Germany overall
from 2.9 to 1.5 (http://www3.rki.de/SurvStat/QueryForm.
aspx). With respect to measles, a disease that occurs
Table 2 Immunization coverage for measles, mumps, and rubella vaccinations in 1,672 students by gender
Study population Doses Measles, n (%) Mumps, n (%) Rubella, n (%)
Total (n=1,672) 0 66 (3.9) 73 (4.4) 178 (10.6)
≥1 1,606 (96.1) 1,599 (95.6) 1,494 (89.4)
≥2 1,275 (76.3) 1,240 (74.2) 1,007 (60.2)
≥3 33 (2.0) 9 (0.5) 27 (1.6)
≥4 6 (0.4) 0 0
Boys (n=741) 0 28 (3.8) 27 (3.6) 96 (13.0)
≥1 713 (96.2) 714 (96.3) 645 (87.0)
≥2 572 (77.2) 558 (75.3) 422 (57.0)
≥3 12 (1.6) 2 (0.3) 1 (0.1)
≥4 2 (0.3) 0 0
Girls (n=931) 0 38 (4.1) 46 (4.9) 82 (8.8)
≥1 893 (96.0) 885 (95.1) 849 (91.2)
≥2 703 (75.5) 682 (73.3) 585 (62.8)
≥3 21 (2.3) 7 (0.8) 26 (2.8)
≥4 4 (0.4) 0 0
Table 3 Immunization coverage for pertussis vaccinations and age at first dose in 1,672 students
Total Doses <1 year, n (%) ≥1 year, n (%) ≥14 years, n (%) Total subjects, n (%)
0 – – – 657 (39.3)
1 25 (1.5) 18 (1.1) 0 43 (2.6)
2 19 (1.1) 28 (1.7) 23 (1.4) 70 (4.2)
3 84 (5.0) 23 (1.4) 1 (0.1) 108 (6.5)
4 590 (35.3) 81 (4.8) 0 671 (40.1)
5 123 (7.4) 0 0 123 (7.4)
≥1 841 (50.3) 150 (9.0) 24 (1.4) 1,015 (60.7)
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Fig. 2 Age when the fifth dose of pertussis component vaccine was
administered in 123 8th grade students
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endemically but also in epidemics in Germany, nationwide
incidence rates were 7.3, 5.6, 0.9, 0.2, and 0.9 in the years
2001–2005. Similarly, the incidence in the city of Erlangen
varied between 0 and 2.9 during the same period with no
major outbreaks reported.
Discussion
Most population-based studies on immunization coverage
have focused on infants and young children [4, 8, 12–14,
16] and on adults for specific vaccines such as those against
influenza and pneumococcal disease [3]. In contrast,
assessment of compliance with recommended immuniza-
tions in adolescents has widely been neglected. In this
regard, the major findings of our study are of concern. We
noted substantial gaps in our study cohort for all standard
immunizations recommended in Germany in adolescents
11–17 years of age. More than 10 years after re-
introduction of pertussis immunization—with specific
recommendations for catch-up vaccinations in older
children and adolescents that could easily be implemented
with the availability of a monovalent acellular pertussis
vaccine at that time—approximately 40% of students were
still unimmunized. Furthermore, less than 10% of those
previously immunized had received a fifth dose of pertussis
vaccine, which had been introduced more than a year
before this study was conducted. Also, more than 50% of
adolescents were underimmunized for tetanus and diph-
theria booster doses. Of further concern, uptake of hepatitis
B immunization, introduced in 1995 for infants and as-yet-
unimmunized adolescents, was disappointingly low, which
renders a substantial part of the population unprotected at
an age when risk of acquisition of this devastating disease
is particularly high [5, 19]. Finally, coverage rates for the
first and second dose of MMR did not meet the targets
established by WHO [23].
Although reported incidences of measles and hepatitis B
in our study area in recent years have been in the same
range or even lower compared to the whole country, it is
obvious from outbreak analyses of vaccine-preventable
diseases that lack of immunization is a major risk factor for
epidemic and endemic disease [1, 10]. In light of this,
recent reports of regional outbreaks of measles in Germany
are not surprising [1] and should be expected in our study
area sooner or later, too. Similarly, epidemics of mumps are
eminent, and an increase in rubella embryopathy cases
could be expected when these adolescents enter child-
bearing age.
Immunizations in adolescents not only were incomplete
but also were administered with significant delays. This
further increases the risk for infections for the individual
and also from a public health perspective [6].
Our study has some limitations. First, participation rate
in this study was less than optimum and unevenly
distributed among the different schools. Therefore, the
true immunization coverage in our adolescent population is
likely to be even lower than the current findings indicate.
Second, this study was not designed to assess the reasons
for underimmunization in adolescents. Probably, missed
opportunities, ignorance regarding the need for catch-up
and booster immunizations, and lack of recall systems are
major factors involved [15, 18], but further investigations
are needed in order to design meaningful interventions.
Third, accuracy of documented immunizations was not
verified with the individuals’ health care providers and
therefore some adolescents may have been misclassified as
not immunized if some vaccinations were administered but
were not documented in the vaccinee’s personal immuni-
zation records. Fourth, this study was performed in 2002.
Immunization rates may have improved since then and
therefore the current situation might be better than the data
we presented imply.
Since the elimination of poliomyelitis by mass immu-
nization with OPV, no newly introduced immunizations in
the national vaccine program in Germany have been
accompanied by official public information campaigns.
Furthermore, over the last three decades, school-based
health services have been downgraded merely to assess
immunization rates in students of various ages (mainly pre-
school and early school age) and to submit written
recommendations to parents on the need of catch-up
immunizations for their children. Immunizations per se are
usually not performed. Rather, administration of vaccines
has been the domain of physicians in private practice
whose task it is to inform and convince patients (or their
parents) about necessary immunizations on an individual
basis. The findings from this study indicate that, in the case
of adolescents, this strategy so far has not been successful
in the region under study. As an indication of potential
improvement, we noted somewhat higher immunization
rates in the youngest age group when compared to the mid-
and late-adolescence age groups, and a recent cohort
analysis also indicates improved vaccination coverage with
the introduction of multicomponent combination vaccines
[13].
Still, achieving sufficient immunization coverage in
adolescents apparently is a difficult challenge and clearly
requires intensified efforts [15, 18]. In this regard, prep-
arations recently discussed in the United States prior to the
introduction of a pertussis booster dose in adolescents in
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Fig. 3 Age when second dose of measles component vaccine was
administered in 536 8th grade students
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October 2005 may serve as an example of how to try to
optimize compliance with immunizations [11]. Raising the
awareness of the benefits of immunizations by information
campaigns, improving opportunities for adolescents to be
immunized in health care settings (e.g. longer office hours,
vaccination programs in schools, or immunizations in new
settings such as emergency departments), reducing “out-of-
pocket costs” (not an issue in Germany where standard
immunizations are covered by health insurances), and
installation of reminder systems (by phone, letter, postcard)
have been identified as most promising strategies [2, 20,
21]. These options should seriously be considered in
Germany, too, if improvement of immunization coverage
in adolescents is our goal.
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